Quinolone-Based Drugs Against Toxoplasma gondii and Plasmodium spp

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|5|3|227-245

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.5, Iss.3, 2005-09, pp. : 227-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral Properties of Quinolone-based Drugs

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 7, 2016-08 ,pp. : 577-586

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Analysis of Stage Specific Gene Regulation of Apicomplexan Parasites: Plasmodium falciparum and Toxoplasma gondii

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 4, 2010-08 ,pp. : 303-311

Bentham Science Publishers

Access to resources Recommend Favorite

Current Treatment and Drug Discovery Against Leishmania spp. and Plasmodium spp.: A Review

By  

Current Drug Targets, Vol. 10, Iss. 3, 2009-03 ,pp. : 178-192

Bentham Science Publishers

Access to resources Recommend Favorite

Invasion and Egress by the Obligate Intracellular Parasite Toxoplasma gondii: Potential Targets for the Development of New Antiparasitic Drugs

By  

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 641-651

Bentham Science Publishers

Access to resources Recommend Favorite